Please enable JavaScript to continue using this application.

Compare $CNTB vs $IBIO | Chartloom

Compare

$CNTB vs $IBIO

Connect Biopharma Holdings Ltd · iBio Inc

CNTB

Connect Biopharma Holdings Ltd

IBIO

iBio Inc

Compare $CNTB vs $IBIO

Comparing Connect Biopharma Holdings Ltd and iBio Inc

CNTBConnect Biopharma Holdings Ltd

IBIOiBio Inc

CNTBConnect Biopharma Holdings Ltd

Market cap

$48M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

5.55x

Rev growth (TTM)

—

YTD performance

-65.5%

52W performance

-52.2%

FCF yield

-125.1%

IBIOiBio Inc

Market cap

$43M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-75.0%

YTD performance

-56.9%

52W performance

0.5%

FCF yield

-55.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CNTB

IBIO

Detailed metrics comparison

CNTB

Connect Biopharma Holdings Ltd

IBIO

iBio Inc

Market Cap

CNTB$48M

IBIO$43M

Enterprise Value

CNTB$21M

IBIO$-13M

Price

CNTB$0.87

IBIO$0.87

P/E Ratio

CNTBN/A

IBION/A

P/S Ratio

CNTB16.42x

IBIO432.71x

EV/Sales

CNTB7.27x

IBIO-131.24x

EV/EBITDA

CNTB0.00x

IBIO0.00x

P/B Ratio

CNTB2.17x

IBIO0.80x

P/FCF Ratio

CNTBN/A

IBION/A

EV/FCF

CNTB-0.35x

IBIO0.55x

PEG Ratio

CNTBN/A

IBION/A

Forward P/E (NTM)

CNTBN/A

IBION/A

Forward P/S (NTM)

CNTB5.55x

IBION/A

Revenue (TTM)

CNTB$3M

IBIO$100K

Revenue Growth (YoY)

CNTBN/A

IBIO-75.0%

Forward Rev Growth

CNTB98.8%

IBIO33.3%

Gross Margin (TTM)

CNTB0.0%

IBIO52.1%

Operating Margin (TTM)

CNTB0.0%

IBIO0.0%

EBITDA Margin (TTM)

CNTB-2361.3%

IBIO-24492.0%

Net Margin (TTM)

CNTB-2336.3%

IBIO-33044.0%

FCF Margin (TTM)

CNTB-2053.3%

IBIO-23796.0%

Net Income (TTM)

CNTB$-69M

IBIO$-33M

FCF (TTM)

CNTB$-61M

IBIO$-24M

EPS (TTM)

CNTB-$1.24

IBIO-$0.23

ROE (TTM)

CNTB-16541.0%

IBIO-4792.0%

ROA (TTM)

CNTB-12158.0%

IBIO-4216.0%

ROIC (TTM)

CNTB-16541.0%

IBIO-4779.0%

Cash

CNTB$27M

IBIO$56M

Debt

CNTB$0

IBIO$0

Net Cash/Debt

CNTB$27M

IBIO$56M

Current Ratio (TTM)

CNTB2.37x

IBIO7.85x

Quick Ratio (TTM)

CNTB2.11x

IBIO7.59x

Debt/Equity (TTM)

CNTB0.00x

IBIO0.91x

Debt/Assets (TTM)

CNTB0.0%

IBIO0.0%

Interest Coverage (TTM)

CNTBN/A

IBION/A

Net Debt/EBITDA (TTM)

CNTB0.00x

IBIO0.00x

Beta

CNTB-0.07

IBIO1.42

52W Performance

CNTB-52.2%

IBIO0.5%

YTD Performance

CNTB-65.5%

IBIO-56.9%

% from 52W High

CNTB-77.2%

IBIO-77.2%

% from 52W Low

CNTB2.3%

IBIO11.5%

Asset Turnover (TTM)

CNTB0.05x

IBIO0.01x

FCF Yield (TTM)

CNTB-125.1%

IBIO-55.0%

Earnings Yield (TTM)

CNTB-142.3%

IBIO-76.4%

Dividend Yield (TTM)

CNTBN/A

IBION/A

Rule of 40

CNTB-2,053.3

IBIO-23,871.0

EV/GP/RG

CNTBN/A

IBION/A

Ticker research

View CNTB research View IBIO research

Metric	CNTB Connect Biopharma Holdings Ltd	IBIO iBio Inc
Market & Valuation
Market Cap	$48M	$43M
Enterprise Value	$21M	$-13M
Price	$0.87	$0.87
P/E Ratio	N/A	N/A
P/S Ratio	16.42x	432.71x
EV/Sales	7.27x	-131.24x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.17x	0.80x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.35x	0.55x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	5.55x	N/A
Revenue & Growth
Revenue (TTM)	$3M	$100K
Revenue Growth (YoY)	N/A	-75.0%
Forward Rev Growth	98.8%	33.3%
Profitability
Gross Margin (TTM)	0.0%	52.1%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-2361.3%	-24492.0%
Net Margin (TTM)	-2336.3%	-33044.0%
FCF Margin (TTM)	-2053.3%	-23796.0%
Net Income (TTM)	$-69M	$-33M
FCF (TTM)	$-61M	$-24M
EPS (TTM)	-$1.24	-$0.23
ROE (TTM)	-16541.0%	-4792.0%
ROA (TTM)	-12158.0%	-4216.0%
ROIC (TTM)	-16541.0%	-4779.0%
Financial Health
Cash	$27M	$56M
Debt	$0	$0
Net Cash/Debt	$27M	$56M
Current Ratio (TTM)	2.37x	7.85x
Quick Ratio (TTM)	2.11x	7.59x
Debt/Equity (TTM)	0.00x	0.91x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.07	1.42
52W Performance	-52.2%	0.5%
YTD Performance	-65.5%	-56.9%
% from 52W High	-77.2%	-77.2%
% from 52W Low	2.3%	11.5%
Efficiency & Yields
Asset Turnover (TTM)	0.05x	0.01x
FCF Yield (TTM)	-125.1%	-55.0%
Earnings Yield (TTM)	-142.3%	-76.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-2,053.3	-23,871.0
EV/GP/RG	N/A	N/A
Ticker research	View CNTB research	View IBIO research

Valuation

P/S Ratio

CNTB

16.42x

IBIO

432.71x

EV/FCF

CNTB

-0.35x

IBIO

0.55x

Growth & revenue

Revenue Growth TTM

IBIO

-75.0%

Forward Revenue Growth

CNTB

98.8%

IBIO

33.3%

Profitability & performance

Gross Margin

IBIO

52.1%

CNTB

0.0%

ROE

IBIO

-4792.0%

CNTB

-16541.0%

FCF Yield %

IBIO

-55.0%

CNTB

-125.1%

52-Week Performance

IBIO

0.5%

CNTB

-52.2%

Detailed metrics comparison

CNTB

Connect Biopharma Holdings Ltd

IBIO

iBio Inc

Market Cap

CNTB$48M

IBIO$43M

Enterprise Value

CNTB$21M

IBIO$-13M

Price

CNTB$0.87

IBIO$0.87

P/E Ratio

CNTBN/A

IBION/A

P/S Ratio

CNTB16.42x

IBIO432.71x

EV/Sales

CNTB7.27x

IBIO-131.24x

EV/EBITDA

CNTB0.00x

IBIO0.00x

P/B Ratio

CNTB2.17x

IBIO0.80x

P/FCF Ratio

CNTBN/A

IBION/A

EV/FCF

CNTB-0.35x

IBIO0.55x

PEG Ratio

CNTBN/A

IBION/A

Forward P/E (NTM)

CNTBN/A

IBION/A

Forward P/S (NTM)

CNTB5.55x

IBION/A

Revenue (TTM)

CNTB$3M

IBIO$100K

Revenue Growth (YoY)

CNTBN/A

IBIO-75.0%

Forward Rev Growth

CNTB98.8%

IBIO33.3%

Gross Margin (TTM)

CNTB0.0%

IBIO52.1%

Operating Margin (TTM)

CNTB0.0%

IBIO0.0%

EBITDA Margin (TTM)

CNTB-2361.3%

IBIO-24492.0%

Net Margin (TTM)

CNTB-2336.3%

IBIO-33044.0%

FCF Margin (TTM)

CNTB-2053.3%

IBIO-23796.0%

Net Income (TTM)

CNTB$-69M

IBIO$-33M

FCF (TTM)

CNTB$-61M

IBIO$-24M

EPS (TTM)

CNTB-$1.24

IBIO-$0.23

ROE (TTM)

CNTB-16541.0%

IBIO-4792.0%

ROA (TTM)

CNTB-12158.0%

IBIO-4216.0%

ROIC (TTM)

CNTB-16541.0%

IBIO-4779.0%

Cash

CNTB$27M

IBIO$56M

Debt

CNTB$0

IBIO$0

Net Cash/Debt

CNTB$27M

IBIO$56M

Current Ratio (TTM)

CNTB2.37x

IBIO7.85x

Quick Ratio (TTM)

CNTB2.11x

IBIO7.59x

Debt/Equity (TTM)

CNTB0.00x

IBIO0.91x

Debt/Assets (TTM)

CNTB0.0%

IBIO0.0%

Interest Coverage (TTM)

CNTBN/A

IBION/A

Net Debt/EBITDA (TTM)

CNTB0.00x

IBIO0.00x

Beta

CNTB-0.07

IBIO1.42

52W Performance

CNTB-52.2%

IBIO0.5%

YTD Performance

CNTB-65.5%

IBIO-56.9%

% from 52W High

CNTB-77.2%

IBIO-77.2%

% from 52W Low

CNTB2.3%

IBIO11.5%

Asset Turnover (TTM)

CNTB0.05x

IBIO0.01x

FCF Yield (TTM)

CNTB-125.1%

IBIO-55.0%

Earnings Yield (TTM)

CNTB-142.3%

IBIO-76.4%

Dividend Yield (TTM)

CNTBN/A

IBION/A

Rule of 40

CNTB-2,053.3

IBIO-23,871.0

EV/GP/RG

CNTBN/A

IBION/A

Ticker research

View CNTB research View IBIO research

Metric	CNTB Connect Biopharma Holdings Ltd	IBIO iBio Inc
Market & Valuation
Market Cap	$48M	$43M
Enterprise Value	$21M	$-13M
Price	$0.87	$0.87
P/E Ratio	N/A	N/A
P/S Ratio	16.42x	432.71x
EV/Sales	7.27x	-131.24x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.17x	0.80x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.35x	0.55x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	5.55x	N/A
Revenue & Growth
Revenue (TTM)	$3M	$100K
Revenue Growth (YoY)	N/A	-75.0%
Forward Rev Growth	98.8%	33.3%
Profitability
Gross Margin (TTM)	0.0%	52.1%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-2361.3%	-24492.0%
Net Margin (TTM)	-2336.3%	-33044.0%
FCF Margin (TTM)	-2053.3%	-23796.0%
Net Income (TTM)	$-69M	$-33M
FCF (TTM)	$-61M	$-24M
EPS (TTM)	-$1.24	-$0.23
ROE (TTM)	-16541.0%	-4792.0%
ROA (TTM)	-12158.0%	-4216.0%
ROIC (TTM)	-16541.0%	-4779.0%
Financial Health
Cash	$27M	$56M
Debt	$0	$0
Net Cash/Debt	$27M	$56M
Current Ratio (TTM)	2.37x	7.85x
Quick Ratio (TTM)	2.11x	7.59x
Debt/Equity (TTM)	0.00x	0.91x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.07	1.42
52W Performance	-52.2%	0.5%
YTD Performance	-65.5%	-56.9%
% from 52W High	-77.2%	-77.2%
% from 52W Low	2.3%	11.5%
Efficiency & Yields
Asset Turnover (TTM)	0.05x	0.01x
FCF Yield (TTM)	-125.1%	-55.0%
Earnings Yield (TTM)	-142.3%	-76.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-2,053.3	-23,871.0
EV/GP/RG	N/A	N/A
Ticker research	View CNTB research	View IBIO research